Latin American drugs

In a rare Spanish takeover of a US company, family-controlled pharmaceutical group Grifols bought plasma specialist Talecris for $3.4bn in August.

 
Top 10

Top 5

  1. Top 5 forces that will shape international finance in 2023
  2. Top 5 female-fronted fintech firms
  3. Top 5 Latin American tech hubs
  4. Top 5 sustainability pioneers in Europe
  5. Top 5 keys to global economic recovery
  6. Top 5 WFH habits, according to the world’s most successful business leaders
  7. Top 5 pandemic-proof industries
  8. Top 5 countries to be world’s next manufacturing hubs
  9. Top 5 most influential and inspirational US economists
  10. Top 5 ways to boost employee engagement and commitment
  11. Top 5 financial services that are ripe for automation
  12. Top 5 ways that GDPR has impacted digital banking
  13. Top 5 emerging fintech hubs across the globe right now
  14. Top 5 ways that the finance industry can prepare for AI
  15. Top 5 economic risk factors that must be considered

In a rare Spanish takeover of a US company, family-controlled pharmaceutical group Grifols bought plasma specialist Talecris for $3.4bn in August.

Related:
  1. Decoding DORA: Navigating the digital regulatory landscape
  2. Building BRIC by BRIC
  3. The quantum joke
  4. Blue bonds could be the answer to financing sustainable development
  5. Tax challenges at the top
  6. We need to talk about bank supervision
  7. Is it time for a coffee cartel?
  8. The sun is setting on Saudi oil
  9. IMF reckoning on fallout with rogue nations
  10. The looming pensions dilemma